276 Matching Annotations
  1. Jun 2017
  2. May 2017
    1. erious gram-negative bacillary infections (especially those due to Pseudomonas aeruginosa) Aminoglycosides are active against most gram-negative aerobic and facultative anaerobic bacilli but lack activity against anaerobes and most gram-positive bacteria, except for most staphylococci; however, some gram-negative bacilli and methicillin-resistant staphylococci are resistant.

      gram negative antibiotic

  3. academic.pgcc.edu academic.pgcc.edu
    1. Staphylococcus epidermidis.  Circular, pinhead colonies which are convex with entire margins.  The colonies of this gram-positive coccus appear either the color of the agar, or whitish.

      for lab - morphology of colonies

    1. ccus spp. in the periodontal pocket and 61.36% in the oral cavity, 27.27% presented thebacteria in both sites. S. epidermidis was the most prevalent specie in the periodontal pocket (15.9%) and oralcavity (27.27%).

      s epi in mouth

    1. URL:http://www.uokufa.edu.iq/journals/index.php/ajb/indexEmail: biomgzn.sci@uokufa.edu.iqISSN: 2073-8854Magazin of Al-Kufa University for Biology/ VOL.5/ NO.2 / year: 2013It was found low percentages of Enterobacterisolates (E. cloacae , E. sakazakii) are able to produce bacteriocin only against sensitive bacteria E.coli. This low production of bacteriocin may be due to siderophore production that can inhibit the activity of bacteriocin such receptor for the uptake siderophore also functions as receptor for the bacteriocin (cloacin)[18].Enterobacterbacteriocin were active against E.coli, but were inactive against Klebsiella pneumoniae, this may be due to the growth inhibitor products of the Enterobacter strains for typing are different in nature [18,24].-Production of RpoSA-Detection of rpoS gene in Enterobacterspp. by PCR.Twenty six isolates (31%) out of 84 isolates of Enterobacter

      rpos

    1. Fortunatelytheinfectionwascontrolledbytopicalsulphacetamideandgentamicindrops.Enterobactercloacaeisusuallyresistanttoampicillinandcanproduceacephalosporinasewhichmaydeactivatesomecephalosporins.'4Aminoglycosideshavebeenthemosteffectivedrugsagainsttheorganismandsepsishasbeentreatedwithcarbenicillinandanaminoglycoside.'H

      antibiotics

    1. Gram-negative organisms were found to be a rare cause of infectious keratitis, with only one case (due to Pseudomonas aeruginosa) in the literature. In an ASCRS survey of 338,550 LASIK pro-cedures, only 2 of 116 cases of infectious keratitis due to Gram-negative organisms were reported.

      rare

    1. Editorial Note Editorial Note: In this investigation pasteurized milk was epidemiologically implicated as the vehicle of transmission of Y. enterocolitica. The temporal and geographic clustering of cases and the negative cultures of subsequent lots of milk are consistent with contamination of a single lot. The mechanism of contamination is unknown. Y. enterocolitica may be found in raw milk (1,2); contaminated raw milk was responsible for an outbreak of yersiniosis among children in Montreal (3). The organism has also been found in pasteurized milk (1,4) although not associated with illness. Y. enterocolitica generally does not survive standard pasteurization (5); however, if present in large enough numbers, viable Yersinia may persist after pasteurization (4-6). Once present in a pasteurized product, the organism grows well at refrigeration temperature (7). Therefore, pasteurization and proper handling of pasteurized milk may not ensure against enteric disease due to Y. enterocolitica. Only two other well documented food-borne outbreaks of Y. enterocolitica enteritis have been reported in the United States: one in New York state in 1976 caused by contaminated chocolate milk (8) and one in Washington state in 1982 caused by tofu (9). Food-borne transmission of yersiniosis has also been suspected in other outbreaks (10-12). This is the largest outbreak of yersiniosis ever reported in the United States.

      historical cases

    1. Metabolism Y enterocolitica is non–lactose-fermenting, glucose-fermenting, and oxidase-negative facultative anaerobe that is motile at 25°C and nonmotile at 37°C. Most, but not all, Y enterocolitica isolates reduce nitrates. The presence of bile salts in the medium prevents the organism from fermenting lactose. Colonies of Y enterocolitica do not produce hy

      test

    2. of Y enterocolitica infection typically include the following: Diarrhea - The most common clinical manifestation of this infection; diarrhea may be bloody in severe cases Low-grade fever Abdominal pain - May localize to the right lower quadrant Vomiting - Present in app

      symptom

    1. e small conserved RNA chaperone protein, Hfq is required for full virulence of a variety of pathogenic bacteria, including both YE and YPT [90]. Hfq is required for expression of the heat-stable enterotoxin Yst in YE [91]

      virulence

    2. YE pathogenicity depends on the presence of the 70-kb plasmid associated with Yersinia virulence, pYV [67, 77–79]. The pYV plasmid differentiates pathogenic from non-pathogenic strains, because it is essential for virulence [79]. The highly pathogenic Y. enterocolitica biotype 1B also harbors the chromosomal high-pathogenicity island (HPI), as do almost all European strains of Y. pseudotuberculosis serotype O1 [69]. HPI encodes proteins that are involved in the biosynthesis, regulation, and transport of the siderophore yersiniabactin [80, 81] and has thus been referred to as an “iron capture island” [63, 69]. There are five main genes within this island (psn, irp1, irp2, ybtP, and ybtQ) that are involved in the yersiniabactin system [80, 82, 83]. This system is positively regulated by YtbA, which is, itself, negatively regulated by the iron-responsive regulator F

      virulence

    3. Subsequently, YE bacilli replicate in Peyer’s patches and can sometimes spread to more distant lymphoid tissues, such as the mesenteric lymph nodes [16–18]. Dissemination from the distal ileum to the spleen and liver is relatively common, followed by extracellular replication and formation of monoclonal microabscesses [19]

      virulence

    4. nfection is usually characterized by a self-limiting acute infection beginning in the intestine and spreading to the mesenteric lymph nodes. However, more serious infections and chronic conditions can also occur, particularly in immunocomp

      progression

    1. The fluoroquinolones are the only direct inhibitors of DNA synthesis; by binding to the enzyme-DNA complex, they stabilize DNA strand breaks created by DNA gyrase and topoisomerase IV. Ternary complexes of drug, enzyme, and DNA block progress of the replication fork. Cytotoxicity of fluoroquinolones is likely a 2-step process involving (1) conversion of the topoisomerase-quinolone-DNA complex to an irreversible form and (2) generation of a double-strand break by denaturation of the topoisomerase. The molecular factors necessary for the transition from step 1 to step 2 remain unclear, but downstream pathways for cell death may overlap with those used by other bactericidal antimicrobials. Studies of fluoroquinolone-resistant mutants and purified topoisomerases indicate that many quinolones have differing activities against the two targets. Drugs with similar activities against both targets may prove less likely to select de novo res

      fluoroquinolone mechanism

    1. Yersinia are oxidase-negative, Gram-negative rods. Use Tables 1 and 2 to identify species and biotype of Yersinia isolates. Currently only strains of Y. enterocolitica biotypes 1B, 2, 3, 4, and 5 are known to be pathogenic. These biotypes and Y. enterocolitica biotype 6 and Y. kristensenii do not rapidly (within 24 h) hydrolyze esculin or ferment salicin (Tables 1 and 2). However, Y. enterocolitica biotype 6 and Y. kristensenii are relatively rare; they can be distinguished by failure to ferment sucrose, and they are pyrazinamidase-positive (28). Hold Y. enterocolitica isolates which are within biotypes 1B, 2, 3, 4, and 5 for further pathogenicity tests.

      tests

    2. nvasion of host cells (ail for Y. enterocolitica and inv for Y. pseudotuberculosis), iron complexing and uptake proteins (irps), and heat-stable enterotoxin (ystA). Factors carried on the 70 kb virulence plasmid (pYV for Y. enterocolitica and pIB1 for Y. pseudotuberculosis) include: the Yersinia outer proteins (yops), low calcium response (lcr), Yersinia adherence protein (yadA), and the temperature dependent transcriptional regulator of many of the other plasmid genes (virF) (38).

      virulence

    1. CDC recommends the use of cefsulodin-irgasan-novobiocin (CIN) agar for isolation of Yersinia spp. from nonsterile sites.   Incubation at 25° C is recommended to prevent loss of the virulence plasmid in Y. enterocolitica. In addition, the lower temperature favors the growth of Yersinia over some other members of the Enterobacteriaceae family that can grow on CIN agar.  

      culture

    2. The incidence of yersiniosis in FoodNet(https://www.cdc.gov/foodnet/index.html) sites in 2014 was 0.28 cases per 100,000 population. This met the U.S. Healthy People 2020 target for yersiniosis of 0.30 or fewer cases per 100,000.

      prevalence

    3. Antibiotics should be given for severe cases. Y. enterocolitica isolates are usually susceptible to trimethoprim-sulfamethoxazole, aminoglycosides, third-generation cephalosporins, fluoroquinolones, and tetracyclines; they are typically resistant to first-generation cephalosporins and most penicillins. They are typically resistant to first-generation cephalosporins and most penicillins. Antimicrobial therapy has no effect on postinfectious sequelae.

      antibiotics and resistance

    1. Yersiniosis usually is diagnosed by detecting the organism in the stool of an infected person. Many laboratories do not routinely test for Yersinia, so it is important to notify laboratory personnel when yersiniosis is suspected so that special tests can be done. The organism can also be recovered from other sites, including the throat, lymph nodes, joint fluid, urine, bile, and blood.

      tests

    1. Common symptoms in children are fever, abdominal pain, and diarrhea, which is often bloody. Symptoms typically develop 4 to 7 days after exposure and may last 1 to 3 weeks or longer. In older children and adults, right-sided abdominal pain and fever may be the predominant symptoms and may be confused with appendicitis. Complications are rare, and may include skin rash, joint pains, or spread of bacteria to the bloodstream.

      symptoms

    2. Pigs are the major animal reservoir for the few strains of Y. enterocolitica that cause human illness, but rodents, rabbits, sheep, cattle, horses, dogs, and cats also can carry strains that cause human illness.

      reservoir

    1. USA and Australia showed case–fatality rates of 14% for nosocomial infections and 5–10% for community-acquired infections (Benin et al., 2002;Howden et al., 2003). In Europe, the overall case–fatality rate is about 12%

      mortality

    1. binding inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erythromycin may be bacteriostatic or bactericidal depending on the organism and drug concentration.

      erythromycin

  4. medical-dictionary.thefreedictionary.com medical-dictionary.thefreedictionary.com
    1. irect fluorescent antibody (DFA) testing has the ability to provide results in a time frame able to influence clinical management and has a specificity of close to 100% (5). However, DFA is technically demanding and insensitive. As with sputum culture, DFA has limited usefulness when patients cannot produce sputum.

      tests

    2. L pneumophila by urinary antigen testing (LPUAT) is a rapid tool for early diagnosis of Legionella infection (6-14). An enzyme immunoassay (EIA) for detecting L pneumophila serogroup 1, which accounts for between 50% and 70% of cases of Legionella p

      test

  5. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    1. nother factor that favors the survival of Legionella in natural or treated waters is its relative resistance to the effects of chlorine and heat; Legionella can find refuge in relatively inhospitable environments such as hot-water tanks.

      PH concern

    2. may appear that we are defenseless against Legionella infection, because the most effective type of host defense shows only very modest bactericidal abilities in vitro. In fact most infections are subclinical, and mortality is low in patients who are not immunocompromised. Similarly, even susceptible experimental animals survive infection unless moderately large doses of bacteria are given. The defense mechanisms probably function better in vivo than in vitro. The action of host defenses may also be additive in vivo. One can construct a scenario by which bacteria are increasingly phagocytosed by cells that do not permit bacterial growth. The net result is a decreasing number of extracellular bacteria and hence a decreased source of infection for a decreasing population of permissive cells. Obsolescent inflammatory cells in the lungs are removed by the mucociliary escalator and expectorated as sputum. Therefore, the infection may begin with a bang, but it ends in most cases with a whimper.

      PH - not a huge concern

    3. The preferred drug for symptomatic Legionella infections is erythromycin. If the patient is seriously ill, it is important to deliver the antibiotic intravenously at first; subsequently, oral therapy may be used. Rifampin is sometimes added as a second antibiotic in seriously ill patients

      antibiotic

    4. his medium contains yeast extract, iron, L-cysteine, and α-ketoglutarate for bacterial growth; activated charcoal to inactivate toxic peroxides that develop in the media; and buffer with a pK at pH 6.9, the optimum for growth of Legionella organisms. Addition of albumin to the media may further facilitate growth of species other than L pneumophila. For contaminated specimens such as sputum, antibiotics should be added. Morphologically distinctive bacterial colonies can usually be detected within 3 to 5 days and identified presumptively as Legionella species if the isolated bacteria depend on cysteine for growth. The identification can be confirmed by specific immunologic typing of the isolated bacteria or, in problematic cases, by molecular analysis.

      growth + test

    5. Virulence appears to be multifactorial. An outer membrane protein that functions as a metalloprotease and a cytoplasmic membrane heat-shock protein elicit protective immune responses, but are not essential for expression of virulence. A gene that encodes a 29 Kd protein and plays a role in cellular infection has been identified. Mutations of the gene are associated with decreased virulence.

      virulence

    6. ymptoms of Legionella infection undoubtedly result from a combination of physical interference with oxygenation of blood, ventilation-perfusion imbalance in the remaining lung tissue, and release of toxic products from bacteria and inflammatory cells. Bacterial factors include a protease that may be responsible for tissue damage. Cellular factors include interleukin-1, which produces fever after it is released from monocytes, and tumor necrosis factor, which may be responsible for some of the systemic symptoms.

      virulence

    7. The bacteria bind to alveolar macrophages via the complement receptors and are engulfed into a phagosomal vacuole. However, by an unknown mechanism, the bacteria block the fusion of lysosomes with the phagosome, preventing the normal acidification of the phagolysosome and keeping the toxic myeloperoxidase system segregated from the susceptible bacteria. The bacilli multiply within the phagosome. Thus, a cellular compartment that should be a death trap instead becomes a nursery. Eventually, the cell is destroyed, releasing a new generation of microbes to infect other cells.

      virulence

    8. rimary growth factor required is L-cysteine, a nutrient that is also essential for Francisella tularensis. Ferric iron is also essential, and other compounds are necessary for optimal growth. Energy is derived from amino acids rather than carbohydrates.

      nutrients to grow

    9. acute pneumonia, which varies in severity from mild illness that does not require hospitalization (walking pneumonia) to fatal multilobar pneumonia. Typically, patients have high, unremitting fever and cough but do not produce much sputum. Extrapulmonary symptoms, such as headache, confusion, muscle aches, and gastrointestinal disturbances, are common. Most patients respond promptly to appropriate antimicrobial therapy, but convalescence is often prolonged (lasting many weeks or even months).

      symptoms and treatment of pneumonia varient

    1. penicillins remain the treatment of choice in most cases of LS, cephalosporins (such as cefoxitin and cefotetan), metronidazole, or clindamycin monotherapy can sometimes be used as first-line drugs owing to the rare emergence of penicillin-resistant strains with β-lactamase activity

      treatment

    1. he association between erythromycin and the ribosome is reversible and takes place only when the 50 S subunit is free from tRNA molecules bearing nascent peptide chains. Gram-positive bacteria accumulate about 100 times more

      resistance to erythromycin

    1. volatile fatty acid profile containing a single major peak of butyric acid (with minor peaks of acetic and propionic acid) is highly indicative of a member of the genus Fusobacterium (49). Unfortunately, these days it is rare for a routine diagnostic

      test

    2. thought that the majority of cases of postanginal sepsis originated in abscesses which were found in the proximity of the tonsil and that these pus collections spread deeper into the loose connective tissue of the pharynx and attach themselves to the walls of the veins, producing purulent periphlebitis and endophlebitis

      virulence?

    3. 0/12 patients were aged between 18 and 29 years. This has been a consistent observation in all later series (Table ​(Table4).4). In the current case series, of 222 cases fitting the Lemierre's syndrome case definition, the median age was 19 years and 89% of patients were aged 10 to 35 years.

      prevalence, mainly young

    4. ta and concluded that F. necrophorum was probably a normal inhabitant of the mucous membranes of humans and commented that “the fact that B. necrophorum has not been found in the normal colon does not indicate that it is not present here but probably that it is present in insufficient numbers to be detected.” I am

      where found

    1. e it binds the CD14/TLR4/MD2 receptor complex in many cell types, but especially in monocytes, dendritic cells, macrophages and B cells, which promotes the secretion of pro-inflammatory cytokines, nitric oxide, and eicosanoids.[15]

      affects immune system

    1. There is a paucity of susceptibility data in the literatureon which to base empirical treatment. However, resistanceto metronidazole has never been reported and susceptibilitydata from 100 human isolates ofF. necrophorumsubmittedto the UK ARL identified 15% resistance to erythromycin,with 2% resistance to penicillin and 1% resistance totetracycline. There was no resistance to metronidazole, co-amoxiclav, chloramphenicol, cefoxitin, clindamycin orimipenem[36]. The level of 15% resist

      resistance

    2. strict anaerobic protocols paying particularattention to minimise the exposure to air of recentlyinoculated agar plates. It is important not to expose micro-colonies ofF. necrophorumto air after overnight incuba-tion; preferably they should have 48 h uninterruptedincubation. In mixed culture, colonies ofF. necrophorummay easily be overlooked particularly by staff unfamiliarwith their typical appearance.

      how to culture

    3. recent study of 248 throat swabs examinedat the University College Hospital in London. This studyfoundF. necrophorumin 10% of patients with sore throats,second only to the incidence of Group A streptococci

      prevalence

    4. lite that can be rapidly detected direct from colonieson an agar plate by using the spot indole reagentp-dimethylcinnamaldehyde. Another readily detectable fea-ture ofF. necrophorumis the production of lipase on anagar medium sup

      biochem tests